GeekWire August 14, 2024
Charlotte Schubert

In a laboratory near downtown Seattle on the shores of Lake Union, Hetu Kamisetty is helping build what he says is the biotech company of the future.

If talent, money and novel technology are any indication, he and his colleagues have a good shot at it.

Kamisetty heads the Seattle location of Xaira Therapeutics, an AI-focused startup launched in April with more $1 billion from investors.

The lab is populated by researchers skimmed from the nearby Institute for Protein Design, the lauded University of Washington research hub and spinout machine.

The founding members of Xaira’s molecule design and AI team, which Kamisetty leads, are all IPD alums.

Nathaniel Bennett helped develop RFDiffusion, an AI-powered tool from the IPD used to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Investments, Pharma / Biotech, Trends
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Axolotl Biosciences Brings Biotech to the Forefront at Formnext 2024
Innovative approach maps gene activity in the living human brain
Trump tariffs could drive up generic drug costs: 5 takeaways
Answer ALS, Cedars-Sinai Collaboration, Single-Cell Protein Profiling, ChapsVision Acquires Sinequa, More

Share This Article